From: Clinical significance of mTOR, ZEB1, ROCK1 expression in lung tissues of pulmonary fibrosis patients
 | IPF | CTD-ILD | p value |
---|---|---|---|
 | (n = 26) | (n = 4) |  |
Age, years, median (range) | 62 (38-74) | 52 (48-55) | 0.139 |
Male sex | 14 (53.8) | 0 | 0.066 |
Ever smoker | 11 (42.3) | 0 | 0.141 |
Pulmonary function test | Â | Â | Â |
  FVC, % | 73.4 ± 15.6 | 78.0 ± 15.9 | 0.746 |
  FEV1, % | 85.4 ± 16.3 | 85.0 ± 17.9 | 0.837 |
  DLCO, % | 62.8 ± 28.8 | 65.7 ± 22.2 | 0.825 |
Histologic fibrosis score | 12.9 ± 8.0 | 8.6 ± 12.9 | 0.220 |
Radiologic honeycombing score | 2.1 ± 1.9 | 1.5 ± 1.9 | 0.791 |
mTOR expression score | 4.4 ± 2.8 | 2.7 ± 4.2 | 0.245 |
ZEB1 expression score | 3.2 ± 2.6 | 2.5 ± 3.0 | 0.576 |
ROCK1 expression score | 3.4 ± 2.9 | 1.7 ± 1.7 | 0.359 |
Steroids or immunosuppressive treatment | 12 (46.2) | 4 (100) | 0.089 |